IMVT
#1041
Immunovant, Inc. - Common Stock
38.5 7 USD
0.00%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.34%
Variación mensual
+14.11%
Variación en los últimos 6 meses
+41.13%
Cambio anual
+100.78%
Cierres anteriores
38.7 0
Open
38.8 2
Mínimo
38.2 7
High
39.0 0
Volumen
163
Financials
- Market Capitalization 7.92 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.97
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1025 |  IBRX ImmunityBio, Inc. - Common Stock | 7.91 USD | +1.54% | -9.60% | +9.10% | +170.89% | 8.28 B USD | ||
| 1026 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 96.96 USD | +3.45% | +9.94% | +18.87% | +305.52% | 8.42 B USD | ||
| 1065 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 61.73 USD | +1.30% | -3.27% | +19.29% | +55.71% | 7.72 B USD | ||
| 1081 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 107.13 USD | -0.33% | -4.88% | +15.19% | -2.88% | 7.34 B USD |